Background: Injection of cement during vertebroplasty and kyphoplasty can leak into surrounding structures and could be symptomatic. Purpose: To identify the sites and incidence of cement extravasation after kyphoplasty and vertebroplasty, and to evaluate their impacts on clinical outcomes. Material and Methods: A retrospective review of 316 patients treated with kyphoplasty and vertebroplasty; 411 cases were included (223 kyphoplasty and 188 vertebroplasty). Cement extravasation was evaluated postoperatively by computed tomography (CT) scan of the spine. Clinical outcomes were assessed by visual analog scale (VAS) and Oswestry Disability Index (ODI).
Introduction
Spinal compression fractures are usually associated with significant morbidity and increased mortality. Treatment is predominately non-surgical except in patients who have neurologic injury and/or disabling pain (1) . When compared to conservative therapy, vertebroplasty and kyphoplasty are both effective surgical treatments for immediate and long-lasting pain relief (2) (3) (4) (5) (6) (7) (8) . Cement injection can leak into the surrounding soft tissues or vertebral venous circulation, which could be symptomatic. In 2009, two randomized controlled trials (RCTs) questioned the efficacy of vertebroplasty (9, 10) . Based on these trials and other reports, the American Academy of Orthopedic Surgeons' published evidence-based guidelines for the treatment of osteoporotic vertebral compression fractures and strongly recommended against the use of vertebroplasty, and called the evidence to use kyphoplasty even weak (11, 12) . Although seemingly disconcerting, new data have emerged calling the previous guidelines into question (13) . The purpose of the current study was to identify the sites and incidence rates of cement extravasation after percutaneous kyphoplasty and vertebroplasty, and to evaluate their impacts on the clinical outcomes and the subsequent sequelae.
Material and Methods
This is a retrospective consecutive case series study. After obtaining institutional review board committee approval, the computerized database was reviewed in the authors' institutions to identify cases of kyphoplasty and vertebroplasty preformed from January 2006 to December 2015. Inclusion criteria were: patients with acute vertebral compression fractures confirmed by magnetic resonance imaging (MRI) or bone scan; and a minimum of 12 months of followup. The duration of conservative treatment was dependent on the patient's presentation. Broadly, there were two groups of patients: the first group presented to the emergency room with severe back pain affecting their ability to mobilize; and the second group consisted of patients who walked into the clinic and could mobilize. In the first group, cement injections were done as soon as they were medically cleared for the procedure. The second group patients were given options of conservative management with lumbar brace or cement injection. The majority of patients in this group had sustained pain affecting their daily activities six weeks or longer after the vertebral fracture.
A total of 316 patients were included in this study (255 women [81%], 61 men [19%]; mean age ¼ 74.3 years; age range ¼ 24-102 years) ( Table 1 ). The authors counted each treated vertebra/level as a single case. The majority of patients had one vertebra treated by either kyphoplasty or vertebroplasty; however, in some patients there was more than one vertebra treated at one or multiple sessions. Multilevel cases of kyphoplasty alone or vertebroplasty alone in the same patient were included, while combined treatment cases (patients received both treatments) were excluded from this study. The maximum number of vertebrae treated at one session was three. The total number of cases/levels included in this study was 411 (223 kyphoplasty and 188 vertebroplasty). Of 411 cases, 329 (80%) were osteoporotic compression fractures (after minor trauma) and 82 (20%) were metastatic compression fractures ( Table 2 ). Although the cause of compression fractures in patients with osteoporosis is obviously different than those with metastasis, there are data to suggest that both do equally well with cement augmentation procedures. Khanna et al. (14) found no statistical difference in improvement after kyphoplasty in patients who had compression fractures due to either osteoporosis or multiple myeloma. Therefore, for the purposes of the current study, patients with compression fractures due to osteoporosis and metastasis can be grouped together.
All patients were neurologically intact and all fractures were acute as confirmed with high signal intensity MRI scan short-tau inversion recovery (STIR). When MRI was contraindicated, acute fracture was confirmed by the increased uptake in three-phase bone scan. All patients had back pain and focal tenderness at the level of the acute fracture.
The treated vertebrae were from T3-L5, with the majority being from T11-L2 (Table 3) (Fig. 1) .
A senior interventional musculoskeletal radiologist and a senior spine surgeon performed all the procedures that were carried out in either the radiology suite under local anesthesia or in the operating room under general anesthesia. All procedures were performed under biplane fluoroscopy, one anteroposterior and one lateral. Kyphoplasty was performed with Kyphon Õ balloon and bone cement from Medtronic (Memphis, TN, USA). Vertebroplasty was performed with Confidence Spinal Cement System Õ from DePuy Synthes (Raynham, MA, USA). A bipedicular approach with balloon inflation was done in kyphoplasty and a unipedicular approach was used in vertebroplasty. Core bone biopsy was routinely taken prior to cement injection to rule out metastasis. Before cement injection the position of each needle's tip was confirmed in both anteroposterior and lateral views. Acceptable positions were as close as possible to midline on anteroposterior view, to get the cement filling across midline, or in the middle of the vertebral body on the lateral view, to lessen posterior cement extravasation into the spinal canal. Bone cement was injected until distribution was felt to be satisfactory. All patients were followed up by upright anteroposterior and lateral plain radiographs. Lador et al. (15) in their study defined cement extravasation as any, small or large, amount of cement leak outside the vertebral body. In the current study, the same criteria were used to identify cement extravasation outside the vertebral body such as in the perivertebral soft tissue, intravertebral disc, segmental vein, and spinal canal when visible on intraoperative fluoroscopy or postoperative plain radiograph. Patients who had cement extravasation were postoperatively evaluated by spinal computed tomography (CT) scan to identify the extent and location of the extravasation. Of the 316 patients, 77 patients had chest CT scans for unrelated reasons. Two independent radiologists reviewed the CT scan images to identify any cement embolization in the chest and the medical charts were reviewed for symptoms related to the cement extravasation, such as postoperative neurological deficit, shortness of breath, postoperative wound infection, and adjacent segment fractures. Clinical outcomes were assessed by means of visual analog scale (VAS) and Oswestry Disability Index (ODI) that were completed by patients preoperatively, in the early postoperative period, and at the last followup. Patient satisfaction and complications of both percutaneous procedures were also recorded. Statistical analyses were performed using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Data are shown as mean AE standard deviation. Student's t test was used for the comparison of continuous variables. Fisher's exact test was used to evaluate the differences of radiological and clinical outcomes between the two groups. P values < 0.05 were accepted for significance.
Results
The mean volume of injected cement was 3.47 cc (range ¼ 1.5-8 cc) in vertebroplasty and 5.7 cc (range ¼ 1-10.5 cc) in kyphoplasty. In vertebroplasty cases, the distribution of cement into vertebral body was unilateral (not crossing the midline on the anteroposterior view) in 94 vertebrae (50%) and bilateral (crossing midline) in 94 vertebrae (50%) (Fig. 2) . In kyphoplasty cases, it was unilateral in 19 vertebrae (8.5%) and bilateral in 204 vertebrae (91.5%). According to the fracture types, cement extravasation was seen in 103/329 vertebrae (31.3%) of the osteoporotic compression fractures and 40/82 vertebrae (48.8%) of the pathologic fractures. Cement extravasation occurred in 81/188 vertebrae (43.1%) in the vertebroplasty group; six of them had extravasation at two sites. Cement extravasation occurred in 67/223 vertebrae (30%) in the kyphoplasty group; eight of them had extravasation at two sites (Table 4 ). In cement-leaked cases of vertebroplasty (81 cases), the sites of local T3  T4  T5  T6  T7  T8  T9  T10  T11  T12  L1  L2  L3  L4 extravasation were as follows: perivertebral soft tissues (n ¼ 33); perivertebral veins (n ¼ 21) (Fig. 3) ; intradiscal space (n ¼ 26); and in the spinal canal (n ¼ 1). In cement-leaked cases of kyphoplasty (67 cases), the sites of local extravasation were as follows: perivertebral soft tissues (n ¼ 30); perivertebral veins (n ¼ 15); intradiscal space (n ¼ 18); and in the intraspinal canal (n ¼ 4). Statistical testing showed that the total cement extravasation rate of kyphoplasty was significantly reduced when compared to that of vertebroplasty (P < 0.006). However, when looking at the individual sites of cement leakage, no difference was found between the two types of surgical treatment (Table 5) .
There was no statistically significant difference between the treatment method and the local extravasation sites (P < 0.05). None of the patients with spinal canal cement extravasation had symptoms of nerve root or spinal cord compression (Fig. 4) . Intradiscal extravasation was seen in 26/81 cement-leaked cases (32.1%) in the vertebroplasty group (188 cases) and in 18/67 cement-leaked cases (26.8%) in the kyphoplasty group (223 cases).
There was no statistically significant difference in the incidence of intradiscal cement extravasation between the kyphoplasty and vertebroplasty groups (P < 0.04). Adjacent vertebral fractures occurred in 3/26 vertebrae (11.5%) in the vertebroplasty subgroup and in 2/18 vertebrae (11.1%) in the kyphoplasty subgroup. In 77 patients, out of 316 that subsequently had chest CT scans for reasons unrelated to the index procedures, only one patient (following multilevel kyphoplasty) was found to have multiple small pulmonary cement emboli and was clinically asymptomatic (Fig. 5) . No postoperative infections were reported in both groups.
The mean VAS decreased from 8.6 preoperatively to 2.8 postoperatively, and to 2.7 at the last follow-up in the kyphoplasty group. The mean VAS decreased from 8.5 preoperatively to 2.7 postoperatively, and to 2.6 at the last follow-up in the vertebroplasty group. The mean ODI scores decreased from 75.80 preoperatively to 26.01 at the last follow-up in the kyphoplasty group. The mean ODI scores decreased from 76.42 preoperatively to 25.56 at the last follow-up in the vertebroplasty group. Both groups showed a statistically significant decrease in both VAS (P < 0.001) and ODI scores (P < 0.001). There was no significantly difference in patient satisfaction between those who had cement extravasation and those who did not, in both groups.
Discussion
The present study showed that both kyphoplasty and vertebroplasty improved the patient's clinical symptoms. In regard of patient satisfaction, there was no significantly difference between these two procedures.
It is worth noting that there has been recent controversy regarding the use of vertebroplasty for osteoporotic vertebral compression fractures, in that contemporary RCTs have provided conflicting data. Buchbinder et al. (9) and Kallmes et al. (10) reported that vertebroplasty was no better than a sham procedure in their RCTs. Conflicting data were then presented by the Vertos II study (16) , which stated that percutaneous vertebroplasty is safe and effective. One major difference between the studies of Buchbinder (9) and Kallmes (10) , vs. Vertos II (16) , is that the former two studies included patients with acute and chronic compression fractures, while the latter only included those with acute compression fractures. In their review of the current literature on the topic, Savage et al. (13) concluded that cement augmentation was worth considering for patients with acute vertebral compression fractures as evidenced by edema on MRI. Similar to the Vertos II (16) study, the current study patient population only included patients with acute compression fractures, and in accordance with Savage et al. (13) acuity of the compression fractures was confirmed using MRI. In earlier studies, cement extravasation rates were reported in the ranges of 11-76% for vertebroplasty and 4.8-39% for kyphoplasty (17) (18) (19) (20) (21) . Taylor et al. (22) reported that cement extravasation was significantly higher with vertebroplasty (40%) than with kyphoplasty (8%). Hulme et al. (23) found similar rates of cement extravasation, (41%) for vertebroplasty and (9%) for kyphoplasty. In the present study, cement extravasation rates were 43.1% in vertebroplasty and 30% in kyphoplasty; both were within the reported ranges.
Injected cement may leak into a variety of anatomical compartments including the prevertebral soft tissue in 6-52.5% of cases, the spinal canal in up to 37.5% of cases, intervertebral disk in 5-25% of cases, prevertebral veins in 5-16.6% of cases, and epidural veins in 16.5% of cases, with also the inferior vena cava and lungs being reported (24) . In the present study, cement extravasation was seen in the perivertebral soft tissues in 40.7% of cases in the vertebroplasty group and in 44.8% of cases in the kyphoplasty group; perivertebral veins in 26% of cases in the vertebroplasty group and in 22.4% of cases in the kyphoplasty group; intradiscal space in 32.1% of cases in the vertebroplasty group and in 26.8% of cases in the kyphoplasty group; and in the spinal canal in 1.2% of cases of the vertebroplasty group and in 6% of cases of the kyphoplasty group. In concordance with previous studies, the most common site of cement extravasation was in the perivertebral soft tissues, 40.7% in vertebroplasty, and 44.8% in kyphoplasty. The literature is inconclusive on the risk of increased adjacent level fractures after these procedures, with rates varying widely for both vertebroplasty (8-52%) and kyphoplasty (3-29%) (25) (26) (27) (28) (29) (30) . In the present study, after reviewing the cases of intradiscal extravasation, the incidence rate of secondary adjacent vertebral fractures was 11.5% in vertebroplasty and 11.1% in kyphoplasty. These findings were in accordance with earlier studies that did not find a distinct correlation between cement augmentation and increased risk of secondary fracture (31) . It has been argued that the injection of too much cement increases the risk of adjacent fractures. The authors compared the cement volumes injected between the group with adjacent fractures and the group without adjacent fractures in all kyphoplasty cases as the kyphoplasty group had the larger volume injected compared to the vertebroplasty. It was found that there was a statistically significant difference between the two groups (P < 0.001). Although this finding supports the hypothesis that too much cement increases risk of adjacent fractures, a sound conclusion cannot be drawn due to the small sample size of adjacent fractures cases in this study. Further focused investigation on this point, with a larger sample size is needed before reaching a sound conclusion. The incidence of PMMA pulmonary cement emboli has been reported to occur in 38-72.5% of patients with pathological vertebral fracture and in 30-65% of patients with osteoporotic fracture in those being treated with vertebroplasty (32) . A systematic review reported the incidence of pulmonary embolism to be in the range of 2-26%, according to the diagnostic method, with most occurrences being asymptomatic (33) . Vasconcelos et al. (34) reported the incidence of minor extravasation of cement into perivertebral veins as 16.6%, including one case in which a minute amount of cement reached the inferior vena cava (0.5%). Venous extravasation of PMMA cement has been frequently noted during vertebroplasty, but most of these leaks are asymptomatic (35) . In the present study, 77/411 cases of vertebroplasty and kyphoplasty had subsequent chest CT scans for reasons not related to the index procedures. Only one case out of 77 (1.3%) was retrospectively diagnosed with cement pulmonary emboli, with no resultant clinical manifestation.
With current restraint in healthcare cost, and pay per performance policy, one has to link a better outcome to justify a higher cost of a procedure. In the current study, although kyphoplasty, when compared to vertebroplasty, has an advantage in terms of better height restoration and less risk of cement extravasation, this did not translate into better functional outcomes such as lower neurological deficit, symptomatic pulmonary embolism, or adjacent vertebral fractures. In view of these findings, one has to question the justification of increased cost with the kyphoplasty in fractures that are not markedly collapsed or in patients with multiple fractures with associated kyphosis.
This study had some inherent limitations of retrospective study such as a selection bias, and follow-up CT scans of the chest were not available in all cases of kyphoplasty and vertebroplasty. Also, the cases were reviewed without respect given to the integrity of the endplate, as an intact or broken endplate could have affected the results. Finally, the physical differences between the cement types were not considered in this study.
In conclusion, kyphoplasty, when compared to vertebroplasty, has an advantage in term of less risk of cement extravasation; however, the majority of cement extravasation cases were asymptomatic. Furthermore, although intradiscal cement extravasation was common in both groups, this did not reflect on increased risk for adjacent vertebral fractures.
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